| 1 |
34778346 | Dietary Phospholipids Prepared From Scallop Internal Organs Attenuate the Serum and Liver Cholesterol Contents by Enhancing the Expression of Cholesterol Hydroxylase in the Liver of Mice. | 2021 |
2 |
| 2 |
34986301 | The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice. | 2021 Dec |
1 |
| 3 |
32003602 | Bile acid treatment and FXR agonism lower postprandial lipemia in mice. | 2020 Apr 1 |
2 |
| 4 |
32006644 | Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy. | 2020 Mar |
1 |
| 5 |
32062620 | Taurine attenuates hepatic steatosis in a genetic model of fatty liver disease. | 2020 |
1 |
| 6 |
32604760 | Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD. | 2020 Jun 26 |
1 |
| 7 |
29986186 | Lipid reducing activity of novel cholic acid (CA) analogs: Design, synthesis and preliminary mechanism study. | 2018 Oct |
1 |
| 8 |
28378930 | Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice. | 2017 Aug |
1 |
| 9 |
29142166 | Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling. | 2017 |
1 |
| 10 |
29216638 | MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1. | 2017 |
1 |
| 11 |
25156247 | Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. | 2015 Apr |
1 |
| 12 |
25425577 | A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. | 2015 Jan 13 |
1 |
| 13 |
25500885 | Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. | 2015 Jan |
1 |
| 14 |
26909306 | Bioenergetic cues shift FXR splicing towards FXRα2 to modulate hepatic lipolysis and fatty acid metabolism. | 2015 Dec |
1 |
| 15 |
24038130 | Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis. | 2014 May |
3 |
| 16 |
24548803 | FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model. | 2014 May |
1 |
| 17 |
24747563 | Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. | 2014 May 23 |
3 |
| 18 |
22197325 | Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. | 2012 Jan 4 |
2 |
| 19 |
22540009 | Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding. | 2012 |
1 |
| 20 |
21862726 | Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. | 2011 Nov |
1 |
| 21 |
19998408 | Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice. | 2010 Mar |
2 |
| 22 |
20431060 | Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease. | 2010 Jun 25 |
2 |
| 23 |
20631352 | A role of the bile salt receptor FXR in atherosclerosis. | 2010 Aug |
1 |
| 24 |
20851881 | The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways. | 2010 Nov 19 |
1 |
| 25 |
18948497 | Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet. | 2009 Jan |
1 |
| 26 |
19028791 | Antiatherosclerotic effect of farnesoid X receptor. | 2009 Feb |
1 |
| 27 |
19126757 | Role of bile acids and bile acid receptors in metabolic regulation. | 2009 Jan |
5 |
| 28 |
19136377 | A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. | 2009 Mar |
2 |
| 29 |
19776172 | The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. | 2009 Dec |
1 |
| 30 |
18000141 | Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression. | 2007 Nov |
1 |
| 31 |
16844773 | Benefit of farnesoid X receptor inhibition in obstructive cholestasis. | 2006 Jul 25 |
2 |
| 32 |
16936198 | Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. | 2006 Sep |
3 |
| 33 |
17110163 | Effects of FXR in foam-cell formation and atherosclerosis development. | 2006 Dec |
3 |
| 34 |
15721319 | Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor. | 2005 Apr 1 |
1 |
| 35 |
14729567 | Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. | 2004 Jan 15 |
3 |
| 36 |
15146238 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. | 2004 May |
1 |
| 37 |
12421815 | The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. | 2003 Jan 24 |
1 |
| 38 |
12891557 | Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. | 2003 Aug |
2 |
| 39 |
11579204 | Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids. | 2001 Oct |
2 |
| 40 |
11030617 | Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. | 2000 Sep 15 |
2 |